Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Targeting angiogenesis for the treatment of sarcoma
Lakshmi Balasubramanian
, Andrew M. Evens
Research output
:
Contribution to journal
›
Review article
›
peer-review
38
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting angiogenesis for the treatment of sarcoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Angiogenesis Inhibitor
100%
Angiogenesis
100%
Sarcoma
100%
Soft Tissue Sarcoma
100%
Therapeutic Procedure
100%
Vasculotropin
66%
Osteosarcoma
66%
Tyrosine-Kinase Inhibitor
66%
Clinical Trial
66%
Neoplasm
33%
Metastatic Carcinoma
33%
Monoclonal Antibody
33%
Lung Cancer
33%
Breast Cancer
33%
Bevacizumab
33%
Randomized Clinical Trial
33%
Tumor Model
33%
Colon Cancer
33%
Platelet Derived Growth Factor
33%
Sarcoma Cell Line
33%
Antiangiogenic Therapy
33%
Bone Tissue
33%
Matrix Metalloproteinase
33%
Tretinoin
33%
Clinical Trial Results
33%
Thalidomide
33%
Urokinase Receptor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Sarcoma
100%
Angiogenesis Inhibitor
75%
Soft Tissue Sarcoma
75%
Osteosarcoma
50%
Urokinase Receptor
25%